Lymphangitis prevention: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (One intermediate revision by one other user not shown) | |||
| Line 11: | Line 11: | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Vascular medicine]] | |||
Latest revision as of 22:36, 29 July 2020
|
Lymphangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangitis prevention On the Web |
|
American Roentgen Ray Society Images of Lymphangitis prevention |
|
Risk calculators and risk factors for Lymphangitis prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]
Overview
Lymphangitis being a manifestation of wide concurrently occurring spectrum of manifestations or pathologies. There is no established method of prevention of lymphangitis. Lymphangitis caused by recurrent skin infections due to group A beta-hemolytic streptococci can be prevented by prophylactic administration of antibiotics can reduce the risk of these skin infections complicating into lymphangitis.
Primary prevention
- There is no established primary prevention for lymphangitis
- Lymphangitis caused by recurrent skin infections due to group A beta-hemolytic streptococci can be prevented by prophylactic administration of antibiotics can reduce the risk of these skin infections complicating into lymphangitis.[1]
References
- ↑ Moran GJ, Abrahamian FM, Lovecchio F, Talan DA (2013). "Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines". J Emerg Med. 44 (6): e397–412. doi:10.1016/j.jemermed.2012.11.050. PMID 23466022.